Financials in GBp. Standardized financial statements.
A compact view of how Deltex Medical Group plc turns revenue into operating income and net income.
| Metric | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue? | £1.78M | £2.48M | £2.26M | £2.40M | £4.26M | £4.96M | £5.87M | £6.33M | £6.41M | £6.51M |
| Revenue Growth? | -28.4% | +9.9% | -5.8% | -43.7% | -14.1% | -15.6% | -7.3% | -1.2% | -1.6% | 0.0% |
| Cost of Revenue? | £651,000 | £735,000 | £776,000 | £851,000 | £1.14M | £1.42M | £1.49M | £2.00M | £2.40M | £1.96M |
| Gross Profit? | £1.13M | £1.75M | £1.48M | £1.55M | £3.12M | £3.53M | £4.38M | £4.33M | £4.01M | £4.55M |
| Gross Margin? | +63.3% | +70.4% | +65.6% | +64.5% | +73.3% | +71.3% | +74.7% | +68.4% | +62.6% | +69.9% |
| Operating Expenses? | £2.18M | £2.79M | £2.64M | £2.59M | £2.99M | £4.68M | £6.32M | £6.70M | £7.50M | £7.54M |
| Operating Income? | -£1.05M | -£1.05M | -£1.16M | -£1.04M | £133,000 | -£943,000 | -£1.94M | -£2.37M | -£3.33M | -£2.99M |
| EBITDA? | -£1.00M | -£819,000 | -£748,000 | -£531,000 | £199,000 | -£731,000 | -£1.48M | -£1.94M | -£3.08M | -£2.73M |
| Income Before Tax | -£1.36M | -£1.22M | -£1.03M | -£846,000 | -£210,000 | -£1.34M | -£2.10M | -£2.52M | -£3.60M | -£3.10M |
| Income Tax Expense | -£83,000 | -£72,000 | -£69,000 | -£61,000 | -£51,000 | -£74,000 | -£100,000 | -£142,000 | -£135,000 | -£144,000 |
| Net Income? | -£1.28M | -£1.15M | -£967,000 | -£798,000 | -£161,000 | -£1.26M | -£2.00M | -£2.38M | -£3.46M | -£2.95M |
| EPS? | £-0.00 | £-0.00 | £-0.00 | £-0.00 | £-0.00 | £-0.00 | £-0.01 | £-0.01 | £-0.02 | £-0.02 |
| Diluted EPS? | £-0.00 | £-0.00 | £-0.00 | £-0.00 | £-0.00 | £-0.00 | £-0.01 | £-0.01 | £-0.02 | £-0.02 |
Revenue, profitability, margins, EPS, and share-count trends over time.
Top-line demand and scale over time
Profit left after direct production costs
Core business profitability before financing and tax
Bottom-line profit after all expenses
Profit allocated to each diluted share
Share count trend that affects EPS quality
Gross, operating, and net margin quality